NASDAQ · Financial Statements
Iterum Therapeutics plc (ITRM) Financial Statements
$0.03
NASDAQ: ITRM
Market Cap $1.60M
Overview Financials Dividend Iterum Therapeutics plc most recently reported annual revenue of $0, net profit of $-25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $0 $0 $0 $0 Operating Profit $-32.0M $-25.0M $-30.0M $-47.0M $-19.0M Net Profit $-52.0M $-92.0M $-44.0M $-38.0M $-25.0M EPS $-32.49 $-8.41 $-3.63 $-2.96 $-1.26 Op Margin — — — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $33.0M $92.0M $67.0M $26.0M $45.0M Total Liabilities $83.0M $41.0M $39.0M $33.0M $49.0M Cash $15.0M $27.0M $21.0M $6.0M $24.0M Borrowings $48.0M $30.0M $30.0M $19.0M $46.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-55.0M $-16.0M $-18.0M $-39.0M $-27.0M Investing Cash Flow $0 $-55.0M $14.0M $23.0M $18.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $10.0M $13.0M $-6.0M $-15.0M $18.0M Free Cash Flow $-55.0M $-16.0M $-19.0M $-39.0M $-27.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.38 FCF Yield -980.34% Quick Ratio 1.96 Interest Coverage -11.67 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock